TP53 and colorectal carcinoma: We previously analyzed the potential seroreactivity of different variants of the p53 family (p53, p73, ΔNp73α, and ΔNp73β) [35] in a subset of our current cohort (healthy, n = 15; PL, n = 19; CRC, n = 9).